Vascular in situ activation radiation therapy insitustent dosimetry

Cardiovasc Radiat Med. 2002 Jul-Dec;3(3-4):193-8. doi: 10.1016/s1522-1865(03)00103-3.

Abstract

Purpose: To investigate the radiation dosimetry of a stable stent following activation by a linac photon beam.

Methods and materials: A computer simulation is used in conjunction with neutron measurements to study the dosimetry of a stent activated by a linac photon beam. Two models are investigated. A gamma emitter, Model G108, with no half-life and 1.43 MeV average energy, and a beta emitter, Model D108, with 2.33 h half-life and 0.45 MeV average energy.

Results: Model D108 delivers a dose exceeding 1 Gy to the artery wall when exposed to an 18-MV photon beam. Model G108 requires a 25-MV photon beam to deliver a similar dose under the same conditions of irradiation.

Conclusion: The very short to no half-life of InSituStent emissions makes the fractionation of the dose delivery possible. In addition, an InSituStent coated with an immunosuppressant drug may give patients the potential benefit of a combined radiation and drug treatments.

MeSH terms

  • Brachytherapy / instrumentation*
  • Brachytherapy / methods*
  • Computer Simulation
  • Coronary Restenosis / radiotherapy*
  • Coronary Restenosis / surgery*
  • Coronary Vessels / radiation effects*
  • Coronary Vessels / surgery*
  • Dose Fractionation, Radiation
  • Endothelium, Vascular / radiation effects
  • Endothelium, Vascular / surgery
  • Humans
  • Models, Cardiovascular
  • Neutron Activation Analysis
  • Particle Accelerators
  • Radiometry*
  • Stents*